Cross-linked poly(trimethylene carbonate) (PTMC) elastomers are widely explored as soft, resorbable implants, yet their dense networks render degradation slow and uncontrollable, limiting predictable clinical performance. This study addresses the long-standing challenge of endowing PTMC elastomers with both structural integrity and controllable, on-demand biodegradation. Methacrylate-terminated PTMC oligomers of varied degrees of polymerization were synthesized and photo-cross-linked in the presence of 1,6-hexanedithiol (HDT). Acting as a competing cross-linker via thiol-ene click chemistry, HDT systematically relaxed the radical-polymerized network. The resulting elastomers exhibited linear surface erosion both in vitro and in vivo, with rates tunable over 1 order of magnitude by varying HDT content while maintaining excellent dimensional stability, achieving degradation levels comparable to medium-molecular-weight linear PTMC. Unlike previous methods that relied solely on radical polymerization or γ irradiation, this supplementary thiol-ene click chemistry-based competition strategy in photo-cross-linking enables direct, quantitative control over cross-linking density and degradation rate of PTMC elastomers. This work establishes a practical platform for fabricating implantable photo-cross-linked PTMC devices with programmable resorption timelines, expanding opportunities for customized drug delivery depots and mechanically matched devices.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: